Anxo Vidal

Universidade de Santiago de Compostela — Spain

Medicine · Health Sciences

34h-index3.7kcitations100works2.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer-related Molecular Pathways(14), Cancer, Hypoxia, and Metabolism(11), Ubiquitin and proteasome pathways(11), RNA Interference and Gene Delivery(9), Nanoparticle-Based Drug Delivery(8)

Publications100 total

SUMOylation of the lysine-less tumor suppressor p14ARF counters ubiquitylation-dependent degradation
Cell Death and Disease·2025· 1 citedOpen Access
Cx43 enhances response to BRAF/MEK inhibitors by reducing DNA repair capacity
Nature Communications·2025· 3 citedOpen Access
Transcriptional repression of <scp>SOX2</scp> by p53 in cancer cells regulates cell identity and migration
International Journal of Cancer·2025· 2 citedOpen Access
Therapeutic applications of a novel humanized monoclonal antibody targeting chemokine receptor <scp>CCR9</scp> in pancreatic cancer
Molecular Oncology·2025· 1 citedOpen Access
Multiparametric super-resolution optoacoustic imaging with ICG-tagged microbubbles
Materials Today Bio·2025Open Access
Author response for "Therapeutic applications of a novel humanized monoclonal antibody targeting chemokine receptor CCR9 in pancreatic cancer"
2025
Scalable Copper Sulfide Formulations for Super‐Resolution Optoacoustic Brain Imaging in the Second Near‐Infrared Window (Small Methods 1/2025)
Small Methods·2025· 1 citedOpen Access
Transcriptional repression of SOX2 by p53 in cancer cells regulates cell identity and migration
2024Open Access
Tunable photoluminescence of electrosynthesized Ag2S@ZnSe quantum dots for nanomedicine applications
Nano-Structures & Nano-Objects·2024· 1 cited
Scalable Copper Sulfide Formulations for Super‐Resolution Optoacoustic Brain Imaging in the Second Near‐Infrared Window
Small Methods·2024· 6 citedOpen Access
Nanotechnology-assisted intracellular delivery of antibody as a precision therapy approach for KRAS-driven tumors
Journal of Controlled Release·2024· 8 citedOpen Access
Cx43 Enhances Response to BRAF/MEK Inhibitors by Reducing DNA Repair Capacity
2024
Nanoemulsions and nanocapsules as carriers for the development of intranasal mRNA vaccines
Drug Delivery and Translational Research·2024· 13 citedOpen Access
Nanoemulsions and nanocapsules as carriers for the development of intranasal mRNA vaccines
2024· 2 citedOpen Access
Biodistribution and pharmacokinetics of [89Zr]-anti-VEGF mAbs using PET in glioblastoma rat models
International Journal of Pharmaceutics·2024· 4 cited
Deep optoacoustic localization microangiography of ischemic stroke in mice
Nature Communications·2023· 51 citedOpen Access
Author Correction: A nanoengineered topical transmucosal cisplatin delivery system induces anti-tumor response in animal models and patients with oral cancer
Nature Communications·2022· 3 citedOpen Access
A nanoengineered topical transmucosal cisplatin delivery system induces anti-tumor response in animal models and patients with oral cancer
Nature Communications·2022· 64 citedOpen Access
Silver Clusters of Five Atoms as Highly Selective Antitumoral Agents Through Irreversible Oxidation of Thiols (Adv. Funct. Mater. 29/2022)
Advanced Functional Materials·2022· 1 cited
Silver Clusters of Five Atoms as Highly Selective Antitumoral Agents Through Irreversible Oxidation of Thiols
Advanced Functional Materials·2022· 20 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Manuel Collado(11), Carmen Rivas(10), Marı́a José Alonso(9), Carlos Diéguez(7), Carmen Carneiro(7), Erea Borrajo(7), Carlos F. de la Cruz-Herrera(7), Manuel S. Rodríguez(7), Andrew Koff(6), Miguel López(6), Rubén Nogueiras(6), Maite Baz-Martínez(6), Fernando Domı́nguez(6), Sabela Da Silva‐Álvarez(5), Tomás García‐Caballero(5), Manuel Serrano(5), Begoña Porteiro(5), Marcos García-Fuentes(5), Alba Ferreirós(4), Gloria Martínez(4)